RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10008 | Rucaparib phosphate; AG014699; PF01367388 | Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for |
| R10010 | Rucaparib; AG-014699; PF-01367388 | Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for |
| R10015 | MN-64 | MN-64 is a inhibitor of tankyrases, showed 6 nM potency against tankyrase 1, iso |
| R10026 | Ruxolitinib (INCB018424) | CAS NO.：941678-49-5Product Name：β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl |
| R10033 | MLN8237 | Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a c |
| R10034 | MK8745 | MK-8745 is a potent and selective Aurora A inhibitor with IC50 of 0.6 nM, more t |
| R10056 | Tubastatin-A | Tubastatin A is a potent and selective HDAC6 inhibitor withIC50 of 15 nM in a ce |
| R10071 | SRT1720 HCl | SRT1720 is a selective SIRT1 activator with EC50 of 0.16 μM in a cell-free assay |
| R10096 | IOX2 | IOX2 is a potent inhibitor of HIF-1α prolyl hydroxylase-2 (PHD2) with IC50 of 21 |
| R10104 | PF03814735 | PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50o |
| R10108 | Olaparib (Synonyms: AZD2281; KU0059436) | Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 |
| R10130 | VX-680 (Tozasertib, MK-0457) | VX-680 (Tozasertib, MK-0457) is a pan-Aurora inhibitor, mostly against Aurora A |
| R10131 | Momelotinib (CYT387) | Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 1 |
| R10153 | Roxadustat (FG-4592) | Roxadustat (FG-4592) is an HIF α prolyl hydroxylase inhibitor in a cell-free ass |
| R10179 | 4SC201 | Resminostat dose-dependently and selectively inhibits HDAC1/3/6 with IC50 of 42. |
| R10191 | Tacedinaline (N-acetyldinaline; CI-994; Goe-5549) | CI994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0. |
| R10213 | SGI1776 | SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 n |
| R10224 | Sirtinol | Sirtinol is a specific SIRT1 and SIRT2 inhibitor with IC50 of 131 μM and 38 μM i |
| R10236 | Talazoparib (BMN 673) | Talazoparib (BMN 673) is a novel PARP inhibitor with IC50 of 0.58 nM in a cell-f |
| R10239 | Tubastain A | Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a c |
| R10247 | Veliparib dihydrochloride; ABT-888 dihydrochloride | Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM a |
| R10269 | FG-2216 (Synonyms: IOX3; YM311) | FG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 uM for PDH |
| R10270 | GSK2801 | GSK2801 is a selective bromodomains BAZ2A/B inhibitor with KD of 257 nM and 136 |
| R10273 | G007-LK | G007-LK is a potent and selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 |
| R10313 | KU0059436; AZD2281; OlaparibIntermediate | Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 |
